IBDEI1I3 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26937,1,3,0)
 ;;=3^340.
 ;;^UTILITY(U,$J,358.3,26937,1,4,0)
 ;;=4^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,26938,0)
 ;;=435.9^^161^1661^6
 ;;^UTILITY(U,$J,358.3,26938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26938,1,3,0)
 ;;=3^435.9
 ;;^UTILITY(U,$J,358.3,26938,1,4,0)
 ;;=4^TIA
 ;;^UTILITY(U,$J,358.3,26939,0)
 ;;=356.9^^161^1661^5
 ;;^UTILITY(U,$J,358.3,26939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26939,1,3,0)
 ;;=3^356.9
 ;;^UTILITY(U,$J,358.3,26939,1,4,0)
 ;;=4^Periperal Neuropathy
 ;;^UTILITY(U,$J,358.3,26939,2)
 ;;=Peripheral Neuropathy^123931
 ;;^UTILITY(U,$J,358.3,26940,0)
 ;;=434.91^^161^1661^1
 ;;^UTILITY(U,$J,358.3,26940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26940,1,3,0)
 ;;=3^434.91
 ;;^UTILITY(U,$J,358.3,26940,1,4,0)
 ;;=4^Acute Stroke
 ;;^UTILITY(U,$J,358.3,26940,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,26941,0)
 ;;=V12.54^^161^1661^3
 ;;^UTILITY(U,$J,358.3,26941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26941,1,3,0)
 ;;=3^V12.54
 ;;^UTILITY(U,$J,358.3,26941,1,4,0)
 ;;=4^HX of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,26941,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,26942,0)
 ;;=294.20^^161^1661^2
 ;;^UTILITY(U,$J,358.3,26942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26942,1,3,0)
 ;;=3^294.20
 ;;^UTILITY(U,$J,358.3,26942,1,4,0)
 ;;=4^Dementia
 ;;^UTILITY(U,$J,358.3,26942,2)
 ;;=^340607
 ;;^UTILITY(U,$J,358.3,26943,0)
 ;;=692.9^^161^1662^2
 ;;^UTILITY(U,$J,358.3,26943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26943,1,3,0)
 ;;=3^692.9
 ;;^UTILITY(U,$J,358.3,26943,1,4,0)
 ;;=4^Contact Dermatitis
 ;;^UTILITY(U,$J,358.3,26944,0)
 ;;=682.9^^161^1662^1
 ;;^UTILITY(U,$J,358.3,26944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26944,1,3,0)
 ;;=3^682.9
 ;;^UTILITY(U,$J,358.3,26944,1,4,0)
 ;;=4^Cellulitis/Abscess
 ;;^UTILITY(U,$J,358.3,26945,0)
 ;;=053.9^^161^1662^3
 ;;^UTILITY(U,$J,358.3,26945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26945,1,3,0)
 ;;=3^053.9
 ;;^UTILITY(U,$J,358.3,26945,1,4,0)
 ;;=4^Herpes Zoster
 ;;^UTILITY(U,$J,358.3,26946,0)
 ;;=696.1^^161^1662^4
 ;;^UTILITY(U,$J,358.3,26946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26946,1,3,0)
 ;;=3^696.1
 ;;^UTILITY(U,$J,358.3,26946,1,4,0)
 ;;=4^Psoriasis
 ;;^UTILITY(U,$J,358.3,26947,0)
 ;;=782.1^^161^1662^5
 ;;^UTILITY(U,$J,358.3,26947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26947,1,3,0)
 ;;=3^782.1
 ;;^UTILITY(U,$J,358.3,26947,1,4,0)
 ;;=4^Rash
 ;;^UTILITY(U,$J,358.3,26948,0)
 ;;=303.90^^161^1663^1
 ;;^UTILITY(U,$J,358.3,26948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26948,1,3,0)
 ;;=3^303.90
 ;;^UTILITY(U,$J,358.3,26948,1,4,0)
 ;;=4^Alcoholism
 ;;^UTILITY(U,$J,358.3,26949,0)
 ;;=300.00^^161^1663^2
 ;;^UTILITY(U,$J,358.3,26949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26949,1,3,0)
 ;;=3^300.00
 ;;^UTILITY(U,$J,358.3,26949,1,4,0)
 ;;=4^Anxiety Disorder
 ;;^UTILITY(U,$J,358.3,26950,0)
 ;;=311.^^161^1663^4
 ;;^UTILITY(U,$J,358.3,26950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26950,1,3,0)
 ;;=3^311.
 ;;^UTILITY(U,$J,358.3,26950,1,4,0)
 ;;=4^Depressive Disorder
 ;;^UTILITY(U,$J,358.3,26951,0)
 ;;=304.90^^161^1663^5
 ;;^UTILITY(U,$J,358.3,26951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26951,1,3,0)
 ;;=3^304.90
 ;;^UTILITY(U,$J,358.3,26951,1,4,0)
 ;;=4^Drug Abuse
 ;;^UTILITY(U,$J,358.3,26952,0)
 ;;=309.81^^161^1663^8
 ;;^UTILITY(U,$J,358.3,26952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26952,1,3,0)
 ;;=3^309.81
 ;;^UTILITY(U,$J,358.3,26952,1,4,0)
 ;;=4^PTSD
 ;;^UTILITY(U,$J,358.3,26953,0)
 ;;=305.1^^161^1663^12
 ;;^UTILITY(U,$J,358.3,26953,1,0)
 ;;=^358.31IA^4^2
